KOD

Kodiak Sciences, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website kodiak.com
Employees(FY) 116
ISIN US50015M1099

Performance

+13.98%

+59.94%

+118.49%

+75.45%

+90.46%

YTD

+138.27%

Profile

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Advanced Technical Analysis

Technical Analysis of KOD 2024-11-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 73 further supports this positive outlook. However, the Oscillators Score of 50 suggests a neutral stance, indicating potential consolidation or indecision in the market, which could temper the overall ...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of KOD

Stock Rank

Recent News & Updates

2024-11-14 03:01
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2024 Financial Results(Prnewswire)
2024-11-10 17:15
Kodiak Sciences to Participate in Upcoming Investor Conferences(Prnewswire)
2024-10-14 05:35
Kodiak Sciences to Present at Innovate Retina 2024(Prnewswire)
2024-09-22 18:00
Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time(Prnewswire)
2024-09-17 04:05
Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City(Prnewswire)
2024-09-12 23:30
Why Is Kodiak Sciences (KOD) Down 8.1% Since Last Earnings Report?(Yahoo Finance)
2024-08-15 22:42
Kodiak (KOD) Q2 Loss Narrower Than Expected, Pipeline in Focus(Yahoo Finance)
2024-08-14 09:54
KOD Stock Earnings: Kodiak Sciences Beats EPS for Q2 2024(Investorplace)
2024-08-14 04:01
Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results(Prnewswire)
2024-07-10 00:00
All You Need to Know About Kodiak Sciences (KOD) Rating Upgrade to Buy(Zacks)
2024-06-19 20:23
Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?(Yahoo Finance)
2024-06-19 20:23
Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?(Zacks)
2024-06-13 23:30
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last Earnings Report?(Zacks)
2024-05-29 04:36
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences(Prnewswire)
2024-05-16 00:51
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus(Zacks)
2024-05-15 10:55
KOD Stock Earnings: Kodiak Sciences Beats EPS for Q1 2024(Investorplace)
2024-05-15 04:01
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results(Prnewswire)
2024-05-13 19:31
Kodiak Sciences dosing subjects in Phase III trial of diabetic retinopathy drug(Yahoo Finance)
2024-05-13 07:32
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy(Prnewswire)
2024-05-02 04:30
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform(Prnewswire)
2024-04-04 00:09
Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks(Zacks)
2024-04-01 05:04
Kodiak Sciences Inc. (NASDAQ:KOD) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-04-01 00:00
Kodiak (KOD) Stock Falls on Q4 Earnings Miss, Pipeline in Focus(Zacks)
2024-03-28 22:36
Q4 2023 Kodiak Sciences Inc Earnings Call(Yahoo Finance)
2024-03-27 23:53
KOD Stock Earnings: Kodiak Sciences Misses EPS for Q4 2023(Investorplace)
2024-03-27 20:32
Kodiak Sciences Inc (KOD) Posts Q4 and Full Year 2023 Financial Results(Yahoo Finance)
2024-03-27 18:30
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results(Prnewswire)
2024-03-25 18:15
Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024(Prnewswire)
2024-01-29 17:30
Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting(Prnewswire)
2024-01-04 03:15
Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference(Prnewswire)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.